Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Necrosis Factor-alpha”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04004910
What this trial is testing

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Who this might be right for
Advanced Breast Cancer
Immunicom Inc 170
Testing effectiveness (Phase 2)Ended earlyNCT00075023
What this trial is testing

Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis

Who this might be right for
Graft-versus-Host DiseaseStomatitis
National Institute of Nursing Research (NINR) 10
Testing effectiveness (Phase 2)WithdrawnNCT04729296
What this trial is testing

Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableStudy completedNCT00893178
What this trial is testing

Impact of Polymorphism on Pulmonary Pressure in Subjects With Pulmonary Hypertension of Different Cause

Who this might be right for
Congestive Heart FailurePulmonary Hypertension
University of Leipzig 350
Not applicableStudy completedNCT02778789
What this trial is testing

Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers

Who this might be right for
Rheumatoid Arthritis
University of Erlangen-Nürnberg Medical School 66
Large-scale testing (Phase 3)UnknownNCT04178850
What this trial is testing

Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection

Who this might be right for
Rheumatoid Arthritis
Genor Biopharma Co., Ltd. 568
Not applicableUnknownNCT04611308
What this trial is testing

The Role of C1q Tumor Necrosis Factor-related Protein 6 in Breast Cancer

Who this might be right for
Breast Cancer
Assiut University 102
Not applicableUnknownNCT02687620
What this trial is testing

Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study

Who this might be right for
Ankylosing SpondylitisAxial Spondyloarthritis
Izmir Katip Celebi University 180
Testing effectiveness (Phase 2)Study completedNCT00126724
What this trial is testing

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Who this might be right for
Arthritis, RheumatoidArthritis, PsoriaticAnkylosing Spondylitis
Targeted Genetics Corporation 120
Not applicableLooking for participantsNCT06538870
What this trial is testing

Dental Implant Healing With TNF-Alpha Inhibitors

Who this might be right for
EdentulismDental ImplantsTNF-alpha Inhibitors
University of Pennsylvania 30
Not applicableLooking for participantsNCT05209776
What this trial is testing

Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy

Who this might be right for
Arrhythmogenic Right Ventricular Dysplasia
University Hospital, Toulouse 80
Not applicableNot Yet RecruitingNCT07129850
What this trial is testing

Bempedoic Acid in PPCI Impact on Clinical Outcome and Inflammatory Markers

Who this might be right for
ST Elevation (STEMI) Myocardial Infarction
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00503425
What this trial is testing

MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 215
Large-scale testing (Phase 3)Ended earlyNCT00042406
What this trial is testing

Trial With HuMax-CD4 in Participants With Rheumatoid Arthritis (RA) Failing Treatment With Methotrexate (MTX) and a TNF-alpha Blocker

Who this might be right for
Rheumatoid Arthritis
Genmab 83
Post-approval studies (Phase 4)Study completedNCT07114016
What this trial is testing

Efficacy of Topical Glucosamine Versus Corticosteroid in Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
Future University in Egypt 36
Post-approval studies (Phase 4)Study completedNCT07121569
What this trial is testing

Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes

Who this might be right for
Ischemic Stroke, Acute
Universitas Sebelas Maret 52
Post-approval studies (Phase 4)Study completedNCT02500641
What this trial is testing

Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout

Who this might be right for
Gout
Menarini International Operations Luxembourg SA 196
Testing effectiveness (Phase 2)Study completedNCT00823173
What this trial is testing

Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis

Who this might be right for
Anterior Uveitis
ESBATech AG 9
Early research (Phase 1)Not Yet RecruitingNCT06385522
What this trial is testing

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Who this might be right for
NHLCutaneous T Cell LymphomaPeripheral T-cell Lymphoma
Boston Immune Technologies and Therapeutics 37
Testing effectiveness (Phase 2)Study completedNCT00019968
What this trial is testing

Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg

Who this might be right for
Stage IVB Adult Soft Tissue SarcomaStage IIB Adult Soft Tissue SarcomaStage IIC Adult Soft Tissue Sarcoma+3 more
National Institutes of Health Clinical Center (CC)
Next Page